(19)
(11) EP 4 798 251 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883220.6

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
A61K 47/68(2017.01)
C12N 15/864(2006.01)
A61K 9/127(2025.01)
A61P 25/28(2006.01)
C07K 16/22(2006.01)
A61K 47/69(2017.01)
C12N 15/113(2010.01)
A61K 47/54(2017.01)
A61K 9/51(2006.01)
A61P 27/02(2006.01)
C12N 15/11(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/127; A61P 27/02; A61P 25/28; C12N 2750/14143; C12N 2750/14145; C12N 2810/859; C12N 2830/003; C12N 2510/00; C07K 16/28; A61K 47/6849; A61K 47/6851; A61K 47/6807
(86) International application number:
PCT/US2024/052497
(87) International publication number:
WO 2025/090565 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363592353 P

(71) Applicants:
  • The Children's Medical Center Corporation
    Boston, MA 02115 (US)
  • The United States Government as Represented by the Department of Veterans Affairs
    Washington, DC 20420 (US)

(72) Inventors:
  • FRANK, Natasha Y.
    Cambridge, MA 02138 (US)
  • FRANK, Markus H.
    Cambridge, MA 02138 (US)
  • WILSON, Brian
    Cambridge, MA 02115 (US)
  • FRANK, Alexander
    New York, NY 10128 (US)

(74) Representative: Potter Clarkson 
Chapel Quarter Mount Street
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) ABCB5-TARGETED STEM CELL REPROGRAMMING AND ANTI-AGING STRATEGIES